Equities researchers at StockNews.com assumed coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a report issued on Sunday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Performance
CHEK stock opened at $1.63 on Friday. Check-Cap has a fifty-two week low of $1.61 and a fifty-two week high of $4.59. The stock’s 50 day simple moving average is $1.90 and its 200 day simple moving average is $2.11. The company has a market cap of $9.54 million, a P/E ratio of -0.54 and a beta of 0.39.
About Check-Cap
Read More
- Five stocks we like better than Check-Cap
- Using the MarketBeat Stock Split Calculator
- The Average 401k Balance by Age Explained
- Best Stocks Under $10.00
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Use Stock Screeners to Find Stocks
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.